Literature DB >> 11775458

The scientific basis of early detection of epithelial ovarian cancer: the National Ovarian Cancer Early Detection Program (NOCEDP).

David A Fishman1, Kenny Bozorgi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11775458     DOI： 10.1007/978-1-4757-3587-1_1

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  17 in total

1.  Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array.

Authors:  Francis Jacob; Darlene R Goldstein; Nicolai V Bovin; Tatiana Pochechueva; Marianne Spengler; Rosemarie Caduff; Daniel Fink; Marko I Vuskovic; Margaret E Huflejt; Viola Heinzelmann-Schwarz
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

2.  DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma.

Authors:  Noriko Yamaguchi; Rei Mimoto; Nozomu Yanaihara; Yoshimi Imawari; Shinichi Hirooka; Aikou Okamoto; Kiyotsugu Yoshida
Journal:  Tumour Biol       Date:  2015-02-25

3.  Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer.

Authors:  Iva Sedláková; Jaroslava Vávrová; Jindřich Tošner; Ladislav Hanousek
Journal:  Tumour Biol       Date:  2011-04

4.  PIK3CA alterations in Middle Eastern ovarian cancers.

Authors:  Jehad Abubaker; Prashant Bavi; Wael Al-Haqawi; Zeenath Jehan; Adnan Munkarah; Shahab Uddin; Khawla S Al-Kuraya
Journal:  Mol Cancer       Date:  2009-07-28       Impact factor: 27.401

5.  Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer.

Authors:  Digant Gupta; Carolyn A Lammersfeld; Pankaj G Vashi; Donald P Braun
Journal:  J Ovarian Res       Date:  2010-10-12       Impact factor: 4.234

6.  Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis.

Authors:  Katherine R Kozak; Malaika W Amneus; Suzanne M Pusey; Feng Su; Mui N Luong; Sam A Luong; Srinivasa T Reddy; Robin Farias-Eisner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

7.  Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma.

Authors:  Carmela De Marco; Nicola Rinaldo; Paola Bruni; Carmine Malzoni; Fulvio Zullo; Fernanda Fabiani; Simona Losito; Marianna Scrima; Federica Zito Marino; Renato Franco; Alfina Quintiero; Valter Agosti; Giuseppe Viglietto
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

8.  Fine needle aspiration cytology of ovarian tumors with histological correlation.

Authors:  Anjali Bandyopadhyay; Jayati Chakraborty; Anadi Roy Chowdhury; Aditi Bhattacharya; Palas Bhattachrya; Mk Chowdhury
Journal:  J Cytol       Date:  2012-01       Impact factor: 1.000

9.  Human papillomavirus genotyping and integration in ovarian cancer Saudi patients.

Authors:  Othman A Al-Shabanah; Mohamed M Hafez; Zeinab K Hassan; Mohamed M Sayed-Ahmed; Waleed N Abozeed; Salem S Al-Rejaie; Abdulmalik A Alsheikh
Journal:  Virol J       Date:  2013-11-20       Impact factor: 4.099

Review 10.  Metastasis of ovarian cancer is mediated by kallikrein related peptidases.

Authors:  Ying Dong; Daniela Loessner; Helen Irving-Rodgers; Andreas Obermair; James L Nicklin; Judith A Clements
Journal:  Clin Exp Metastasis       Date:  2013-09-17       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.